Clinical Trial Update: Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer

View source ↗

Summary

A clinical trial from Atlas University is currently recruiting to evaluate whether circulating microRNAs can predict pathological response to neoadjuvant chemot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Atlas University | Conditions: Breast Cancer, Neoadjuvant Therapy | Status: RECRUITING